Inogen (INGN) Cash from Investing Activities Growth (1y) (2014 - 2026)
Inogen (INGN) Cash from Investing Activities Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 0.00% |
| 10 | Inogen | 151.99 Mn | 46.45 Mn | 43.27 Mn | 86.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 86.12% |
| Mar 31, 2026 | 3.09% |
| Dec 31, 2025 | -113.14% |
| Sep 30, 2025 | -126.89% |
| Jun 30, 2025 | -82.39% |
| Mar 31, 2025 | 84.84% |
| Dec 31, 2024 | 179.55% |
| Sep 30, 2024 | 100.67% |
| Jun 30, 2024 | -2,191.85% |
| Mar 31, 2024 | 21.43% |
| Dec 31, 2023 | 159.45% |
| Sep 30, 2023 | -863.05% |
| Jun 30, 2023 | -111.08% |
| Mar 31, 2023 | -322.26% |
| Dec 31, 2022 | 43.90% |
| Sep 30, 2022 | -512.05% |
| Jun 30, 2022 | 210.57% |
| Mar 31, 2022 | -510.95% |
| Dec 31, 2021 | 33.18% |
| Sep 30, 2021 | 114.48% |